Graphical Abstract Highlights d Human DCs possess endomembranal CCR7 and orient the TGN toward the cell front d The endomembrane CCR7 pool is formed by de novo synthesis and receptor trafficking d Chemokines initiate a signaling complex including CCR7, Vav1, and Rac1 at the TGN d b-arrestin and Src are required to drive the endomembranal CCR7 signaling complex In Brief Laufer et al. identify a role for an endomembrane pool of the chemokine receptor CCR7 in dendritic cells. They demonstrate that chemokine triggering at the cell surface initiates the formation of an endomembrane signaling complex comprising CCR7, Vav1, and Rac1. They found that endomembranal Rac1 activation results in lamellipodia formation.
INTRODUCTION
Chemokines are pivotal orchestrators of cell migration. Locally produced chemokines provide essential guidance cues not only for organogenesis, regeneration, and immune surveillance but also for the development of many diseases (Thelen and Stein, 2008) . To promote directional migration, cells must be able to read guidance cues and translate the spatial information of the chemokine gradient into persisting signaling cascades resulting in cell polarization and directed migration (Sarris and Sixt, 2015) . Leukocytes recognize chemokines through cognate chemokine receptors, which belong to the G-protein-coupled receptor (GPCR) superfamily and signal through heterotrimeric G proteins for cell migration (Legler and Thelen, 2018) . In addition, chemokine receptors, like CCR7, are phosphorylated on serine/ threonine residues situated at the receptor's tail by either GPCR kinases (GRKs) (Zidar et al., 2009) or second-messenger-dependent protein kinases (Kohout et al., 2004) , leading to the recruitment of b-arrestins and, consequently, internalization of the receptor into clathrin-coated pits (Otero et al., 2006) . In general, internalized receptors were initially considered to be silenced or desensitized. For instance, internalization and sorting to lysosomes for degradation was found to terminate signaling by CXCR4 (Marchese and Benovic, 2001) . However, other receptors, including CCR7 and CCR5, enter the recycling pathway to be delivered back to the plasma membrane, where they replenish the cell surface with ''fresh,'' ligand-free receptors that re-participate in chemokine sensing (Mueller and Strange, 2004; Otero et al., 2006 Otero et al., , 2008 . Both pathways do not explain how chemokines control sustained directional cell migration.
The paradigm that canonical GPCR-mediated activation of heterotrimeric G proteins is confined to the plasma membrane has recently been challenged. Importantly, sustained b 2 -adrenergic receptor (b 2 AR) signaling from endosomes was found to involve not only the GPCR and its cognate G protein but also b-arrestin (Irannejad et al., 2013; Thomsen et al., 2016) .
To explore potential chemokine receptor signaling from endomembranes and its contribution to guided cell migration, we used CCR7 as a model system. CCR7, together with its ligands, CCL19 and CCL21, controls a diverse array of migratory events in health and disease (Fö rster et al., 2008; Hauser and Legler, 2016; Legler et al., 2014) . Most prominently, CCR7 is essential for guiding dendritic cells (DCs) and lymphocytes from peripheral tissues via lymph or blood vessels into lymph nodes from where they launch an adaptive immune response (Fö rster et al., 2008) . Interestingly, a fraction of CCR7 is known to constitutively reside in endomembrane compartments, including early endosomes and the trans-Golgi network (TGN) . Beside steady-state trafficking of CCR7 in the absence of ligands, CCL19 stimulation results in profound ligand-induced receptor internalization (Bardi et al., 2001; Otero et al., 2006) involving b-arrestins (Kohout et al., 2004; Comerford et al., 2006) . Internalized CCR7 is then recycled back to the plasma membrane through the TGN route , similarly to CCR5 (Escola et al., 2010) . Here, we show that upon chemokine stimulation, b-arrestins and Src kinase conjointly traffic to endomembranes, including the TGN, where Src phosphorylates CCR7 to form an endomembrane-residing signaling complex comprising the chemokine receptor, the RhoGEF Vav1, and its (legend continued on next page) effector, Rac1. We found that the TGN and the Golgi often orient toward the leading edge of migrating DCs. Moreover, we provide evidence that Rac1 activation at endomembranes promotes local lamellipodia formation at the cell's leading edge, a prerequisite for directional cell migration.
RESULTS

Leukocytes Possess Distinct Intracellular Pools of CCR7
Continuous CCR7 signaling over the timescale of hours is key for leukocyte motility in chemokine-rich lymph nodes (Fö rster et al., 2008) , while chemokine-triggered CCR7 itself has been shown to be rapidly (in seconds/minutes) desensitized (Yoshida et al., 1998; Kohout et al., 2004) , internalized (Bardi et al., 2001; Otero et al., 2006) , and subsequently recycled back to the plasma membrane to re-participate in chemokine recognition and cell migration . These somehow opposing observations raise the question of how continuous CCR7 signaling is maintained despite receptor desensitization and internalization. Notably, under steady-state conditions, GFPtagged CCR7 expression was previously found not only at the plasma membrane but also at endomembranes, such as early endosomes and the TGN (Otero et al., 2006; Schaeuble et al., 2012) . To explore potential endomembrane chemokine receptor signaling, we first reevaluated the localization of endogenous CCR7 in primary human leukocyte subsets under steady-state conditions by flow cytometry ( Figure S1A ). We found that the majority of CCR7 was expressed at the plasma membrane of sorted CD3 + T and CD19 + B lymphocytes isolated from blood of healthy human donors ( Figure 1A) . Nonetheless, approximately one-third of the receptor constitutively localized intracellularly. Immature human monocyte-derived dendritic cells (iDCs) expressed only low levels of CCR7 ( Figures 1B and 1C ) Hauser et al., 2016b) , and most of it was found intracellularly ( Figure 1A ). As expected, CCR7 expression was significantly upregulated on human monocyte-derived DCs matured with a cocktail of pro-inflammatory cytokines (mDCs) on mRNA and protein levels (Figures 1B and 1C) . To our surprise, a large proportion of CCR7 in mDCs was still found intracellularly ( Figure 1A ). As efficient DC migration toward CCR7 ligands requires a second signal provided by prostaglandin E 2 (PGE 2 ) Hauser et al., 2016b) , we addressed CCR7 localization on DCs matured by cytokine cocktail supplemented with PGE 2 . Supplementation of PGE 2 resulted in partial redistribution of CCR7, but roughly 60% of CCR7 remained intracellularly ( Figures 1A and S1B ). We further investigated CCR7 localization by confocal microscopy. In mDCs CCR7 localized at the plasma membrane and at intracellular compartments, where the receptor partially associated with TGN46 ( Figure 1D ). Our data reveal that under steady-state conditions, CCR7 is constitutively present not only at the plasma membrane but also at endomembranes of primary human leukocytes. Notably, the pool of intracellular-residing CCR7 varies among different leukocyte subsets, being highest in DCs.
Inspired by the finding that CCR7 partially resides at the TGN, we assessed TGN localization in migrating mDCs. Therefore, we let human mDCs migrate in 3D collagen along a CCL19 or CCL21 gradient, fixed and permeabilized the cells in situ, and stained for TGN46 and the nucleus. Notably, the TGN often localized in front of the nucleus and oriented toward the leading edge ( Figure 1E ). Similarly, time-lapse video microscopy of migrating mDCs revealed that the Golgi predominantly oriented, either transiently or persistently, toward the leading edge while cells migrated along chemokine gradients ( Figure 1F ; Video S1).
Steady-State Trafficking and De Novo Synthesis Conjointly Establish the Endomembrane CCR7 Pool
To further investigate the role of the intracellular CCR7 pool, we used HEK293 cells as model system, as primary cells are not convenient for genetic manipulation. We first expressed untagged, YFP-tagged, and YFP2-tagged CCR7 in HEK293 cells (Figures 1G and 2A) , assuring that expression of the receptor in HEK293 cells and tagging the receptor does not affect its localization. We then stably expressed CCR7-YFP in HEK293 cells and analyzed plasma membrane and TGN residency of the receptor (Figure 2A ) . To examine how the intracellular pool of CCR7 is established, we treated cells with dynasore to prevent dynamin-mediated receptor endocytosis and/or cycloheximide to inhibit de novo protein synthesis and determined the mean fluorescence intensity (MFI) of CCR7-YFP in a confocal z stack at the plasma membrane or at the TGN relative to the MFI of the corresponding whole-cell area (Figures 2B and 2C) . Dynasore treatment shifted the ratio of the MFI of CCR7-YFP toward the plasma membrane ( Figure 2B ). Consistent with this, the calculated Pearson's (B and C) Upregulation of CCR7 upon maturation of DCs in the presence or absence of PGE 2 . CCR7 mRNA expression was measured on mRNA level by quantitative real-time PCR (B) or on protein level by western blotting (C). Data are derived from six independent donors (mean ± SEM) (B) or one representative donor, and mean values (±SEM) from three donors are shown (C). (D) Human mDCs matured in the presence or absence of PGE 2 were stained for CCR7 and TGN46 and analyzed by confocal microscopy. Depicted are representative micrographs from one donor out of three. Scale bars, 10 mm. Colocalization was analyzed by calculating the Pearson's correlation coefficients of CCR7 and TGN46 (mean ± SEM). (G) Subcellular localization of untagged CCR7 and CCR7-YFP2 examined in HEK293 cells using a CCR7-specific antibody. One experiment out of three; scale bars, 10 mm. See also Figure S1 . correlation coefficient of colocalization between CCR7-YFP and TGN46 was reduced in dynasore-treated cells ( Figure 2F ). Similar results were obtained when clathrin-mediated endocytosis was blocked by small interfering RNA (siRNA) knockdown of the clathrin heavy chain (CHC) or the AP2m2 chain (Motley et al., 2003) (Figures 2J-2L ). Treating cells with cycloheximide reduced the MFI of CCR7-YFP at the TGN relative to the entire cell area, while the proportion of CCR7 at the plasma membrane did not significantly change ( Figures 2B, 2C , and 2F). Furthermore, the Pearson's correlation coefficient of CCR7-YFP and TGN46 significantly decreased in cycloheximide-treated cells (Figures 2C and 2F) . Combining dynasore and cycloheximide significantly shifted the balance toward plasma-membraneresiding CCR7-YFP, while the relative amount of TGN-associated CCR7-YFP was profoundly reduced ( Figure 2B ). Further analysis revealed that CCR7-YFP barely localized in early endosomes stained for EEA1 (Figures 2D and 2G) or the endoplasmic reticulum (ER) stained for Climp63 (Figures 2E and 2H) . Nevertheless, dynasore or cycloheximide treatment further reduced the calculated Pearson's correlation coefficient of CCR7-YFP and EEA1 or CCR7-YFP and Climp63, respectively ( Figures 2D, 2E , 2G, and 2H). These data suggest that steadystate CCR7 trafficking from the plasma membrane to endomembranes together with trafficking along the secretory pathway of newly synthesized receptors jointly establish the endomembrane-residing CCR7 pool.
The contribution of the secretory pathway in the formation of the endomembrane receptor pool was further investigated using the retention using selective hooks (RUSH) system (Boncompain et al., 2012) . Therefore, we fused GFP-tagged CCR7 to a streptavidin-binding peptide and co-expressed it together with an ER-anchored hook fused to streptavidin, resulting in ER-retained RUSH-CCR7-GFP ( Figure S2A ). Addition of biotin allows a synchronous release of newly synthesized CCR7 from the hook and therefore the ER. After 30 min of biotin addition, much of the RUSH-CCR7-GFP had left the ER, as the Pearson's correlation coefficient between RUSH-CCR7-GFP and Climp63 had dropped ( Figure S2A ). Simultaneously, RUSH-CCR7-GFP started to associate with the Golgi and TGN46, where it accu-mulated over time ( Figure S2B ). In the RUSH system, only a minor fraction of RUSH-CCR7-GFP reached the plasma membrane 48 h after simultaneously releasing CCR7 from the ER ( Figure S2C ). In contrast, using the same system, CCR5, which also recycles via the TGN (Escola et al., 2010) , has readily passed the TGN area after 4 h of biotin addition on its way to the plasma membrane ( Figures S2A-S2C ). Consistent with this, ER-released RUSH-CCR5-GFP reached the plasma membrane within 4 h, whereas after 48 h, the TGN was almost completely discharged ( Figures S2B and S2C ). Moreover, CCR5 possess only a minor intracellular pool in lymphocytes and mDCs ( Figure S1C ). Hence, we found substantial differences in continuous intracellular trafficking between CCR7 and CCR5. These data further support that trafficking along the secretory pathway of newly synthesized receptors together with steady-state receptor trafficking jointly forms an endomembrane-residing CCR7 pool.
Identification of an Endomembrane Residing CCR7 Signaling Complex
In a screen for interaction partners of CCR7, we identified the RhoGEF Vav1 to directly associate with activated, tyrosine phosphorylated CCR7 , but neither the localization of the interaction nor its function had been investigated. Thus, we analyzed CCR7:Vav1 interaction in situ by proximity ligation assay (PLA) in human mDCs. As expected, we hardly observed an interaction of endogenous CCR7 with endogenous Vav1 in unstimulated mDCs ( Figure 3A ). Stimulation of mDCs with CCR7 ligands, however, enhanced CCR7:Vav1 PLA, supporting that the recruitment of Vav1 to CCR7 depends on chemokine triggering ( Figure 3A) . Surprisingly, CCR7:Vav1 interaction was mainly found at intracellular compartments as manifested by intracellular red fluorescent dots seen in 3D reconstructions of confocal images ( Figure 3A ). To gain information on the dynamics of the CCR7:Vav1 interaction, we conducted Fö rster resonance energy transfer (FRET) measurements in HEK293 cells expressing CCR7-CFP and Vav1-YFP. Chemokine stimulation resulted in rapid and transient recruitment of Vav1 to CCR7, which peaked after $1-5 min and ceased after 10 min (I) HEK293 cells stably expressing CCR7-YFP were pretreated or not with dynasore and stimulated for 30 min with 0.5 mg/mL CCL19 or CCL21 or left unstimulated. CCR7 surface expression was determined by flow cytometry. Data represent mean ± SEM of three independent experiments. (J) Knockdown of CHC or AP2m2 significantly reduces the TGN-resident CCR7 pool. HEK293 cells stably expressing CCR7-YFP were transfected with control siRNA or siRNA targeting CHC or AP2m2 and colocalization of CCR7-YFP and TGN46 was analyzed (mean ± SEM of three independent experiment) and depicted as Pearson's correlation coefficient. (K) siRNA knockdown of CHC or AP2m2 significantly reduces ligand-induced CCR7 endocytosis. HEK293 cells stably expressing CCR7-YFP were transfected with control siRNA or siRNA targeting CHC or AP2m2 and stimulated for 30 min with 0.5 mg/mL CCL19 or CCL21 or left unstimulated. Data represent mean ± SEM of three independent experiments. (L) Western blot analysis of HEK293 cells stably expressing CCR7-YFP were transfected or not with control siRNA or siRNA targeting CHC (left upper panel) or AP2m2 (left lower panel). One representative western blot and quantification of three independent experiments is shown (mean ± SEM, right panels). See also Figure S2 .
( Figures 3B and S3G ). Next, we exploited split-YFP based bimolecular fluorescence complementation (BiFC), which we have successfully used to monitor Src recruitment to activated CCR7 . To do this, we fused two YFP fragments, termed YFP1 and YFP2, to either CCR7 or Vav1. Upon interaction of CCR7-YFP2 with Vav1-YFP1, the two nonfluorescent halves of YFP1 and YFP2 will reconstitute to native YFP that emits its fluorescent signal upon excitation. BiFC was One representative micrograph from one of three independent donors is shown. Shown is quantification of PLA signal (Vav1:CCR7) as MFI (mean ± SEM). Scale bars, 10 mm. (B) CCR7:Vav1 interaction determined by FRETsensitized emission. HEK293 cells stably expressing Vav1-YFP were transiently transfected with CCR7-CFP and stimulated with 0.5 mg/mL CCL19 or CCL21 for the indicated time points (mean ± SEM). (C) Analysis of chemokine-driven CCR7:Vav1 BiFC formation and colocalization with TGN46 or EEA1. HEK293 cells were transiently transfected with Vav1-YFP1 and CCR7-YFP2, stimulated with 0.5 mg/mL CCL19 or CCL21 and monitored by confocal microscopy. One experiment out of three is shown (mean ± SEM). (D) Quantification showing the MFI of BiFC in HEK293 cells transiently transfected with Vav1-YFP1 and CCR7-YFP2, stimulated for 3 min with 0.5 mg/mL CCL19 or CCL21, and monitored by confocal microscopy (mean ± SEM); where indicated, cells were pretreated for 30 min with dynasore (80 mM). (E) N-terminally StrepII-tagged CCR7-YFP1 and Vav1-YFP2 were transiently co-transfected into HEK293 cells, and surface CCR7 was directly labeled with StrepTactin 568 . CCR7:Vav1 BiFC was visualized after stimulation of cells with 0.5 mg/mL CCL19 or CCL21. One experiment out of three is shown. Scale bars, 10 mm. (F) Analysis of colocalization of the BiFC signal of Vav1-YFP2 and N-terminally StrepII-tagged CCR7-YFP1 with CCR7 that was surface labeled with StrepTactin 568 in transiently transfected HEK293 cells. Colocalization of BiFC and Strep-Tactin 568 was analyzed after stimulating cells with 0.5 mg/mL CCL19 or CCL21 (mean ± SEM) and depicted as Pearson's correlation coefficient. See also Figure S3 .
hardly observed in nonstimulated cells, as assessed by confocal microscopy (Figures 3C and S3A) . In contrast, chemokine stimulation resulted in profound CCR7:Vav1 BiFC at endomembranes with no ligand bias ( Figures 3C, 3D , and S3A; Video S2). Chemokine-dependent CCR7:Vav1 BiFC was found predominantly in the TGN region ( Figure 3C ), as well as at the GM130-positive cis-Golgi and the Giantin-positive medial-Golgi region ( Figures S3D-S3F ), but barely in EEA1-positive early endosomes ( Figure 3C ). Unexpectedly, but in line with the PLA data, we hardly observed CCR7:Vav1 BiFC at the plasma membrane. Interestingly, chemokine-induced formation of CCR7:Vav1 BiFC was not inhibited by dynasore (Figures 3D and S3H) that significantly inhibits ligand-induced CCR7 endocytosis ( Figures 2I and S3I ). In the light of ligand-biased signaling, where CCR7 is internalized by CCL19 but less by CCL21 (Otero et al., 2006; Hauser and Legler, 2016) , we generated a StrepII-CCR7-YFP1 variant with an N-terminal StrepII-tag permitting labeling of surface receptor with fluorescent Strep-Tactin without affecting chemokine-driven receptor endocytosis and trafficking ( Figure S3J ). In unstimulated cells, StrepTactin surface-labeled StrepII-CCR7-YFP1 was nicely detected at the plasma membrane, whereas no CCR7:Vav1 BiFC was observed ( Figure 3E ). Stimulation of cells with CCL21 resulted in profound CCR7:Vav1 BiFC at endomembranes, whereas StrepTactinlabeled CCR7 remained largely at the plasma membrane (Figure 3E) . Consistently, CCR7:Vav1 BiFC barely colocalized with StepTactin-labeled CCR7 ( Figure 3F ). CCL19 stimulation resulted in substantial internalization of surface-labeled CCR7, as StrepTactin-labeled CCR7 was readily observed in vesicular structures ( Figure 3E ). Many of these StrepTactin-positive vesicles observed upon CCL19 stimulation were YFP negative, and many of the YFP (CCR7:Vav1 BiFC)-positive vesicles comprising the endosomal signaling complex were devoid of the StrepTactin-label ( Figures 3E and 3F ). These data suggest that a common signaling pathway elicited by CCL19 and CCL21 initiated at the plasma membrane is able to drive the recruitment of Vav1 to endomembrane-residing CCR7.
Src Is Key to Form the Endomembrane CCR7 Signaling Complex
To dissect the CCR7 signaling cascade initiated at the plasma membrane that drives endomembrane-specific CCR7:Vav1 interaction, we pharmacologically blocked G i -protein activation by pertussis toxin (PTx). Intriguingly, chemokine-driven CCR7-YFP2:Vav1-YFP1 BiFC at endomembranes was insensitive to PTx treatment ( Figures 4A-4C ). Similar results were obtained by using a CCR7-DNY-YFP2 mutant (Figures 4A-4C; Video S3) that is known not to transmit G i -protein-dependent signals (Otero et al., 2008) . We recently identified that chemokine-binding results in tyrosine phosphorylation at residue Y155 of CCR7 by Src kinase, creating a docking site for SH2-domain-containing signaling molecules . Expressing a tyrosine-phosphorylation-defective CCR7-Y155F-YFP2 mutant showed comparable subcellular localization to CCR7-YFP2 ( Figures 4E , S3B, and S3C). However, chemokine-induced BiFC was abrogated between Vav1-YFP1 and CCR7-Y155F-YFP2 ( Figure 4D-F) . This finding was corroborated by treating cells expressing CCR7-YFP2 and Vav1-YFP1 with the Src kinase inhibitor PP2 or by overexpressing a kinase-dead form of Src (SrcKD) (Figures 4D, 4F, and S4H) . Expressing just the SH3-SH2-SH3 domains of Vav1 fused to YFP1 was sufficient for recruitment to endomembrane-residing CCR7-YFP2 upon chemokine stimulation ( Figure S4E ). This supports the idea of tyrosine-phosphorylated CCR7 at endomembranes being a docking site for the SH2-domain of Vav1. These data provide clear evidence that chemokine-driven Src kinase activity is essential for establishing the endomembrane CCR7:Vav1 signaling complex.
To further investigate the role of Src in transmitting the signal from the plasma membrane to endomembranes, we exploited recruitable Src kinase variants. We expressed either TGN-or plasma-membrane-resident recruiters that harbor the rapamycin-inducible dimerization-domain FRB (Szentpetery et al., 2010) in HEK293 cells. Upon addition of rapamycin, Src-FKBP12-mRFP translocated to the cognate recruiter. By directly targeting Src to the TGN, we found that Src is sufficient to recruit Vav1-YFP1 to TGN-residing CCR7-YFP2, independently of extracellular chemokine stimulation ( Figures S4A and  S4C) . The endomembrane CCR7:Vav1 BiFC complex was not established when SrcKD-FKBP12-mRFP was recruited to the TGN or when Src-FKBP12-mRFP was targeted to the plasma membrane ( Figures S4B-S4D) . These results support the notion that trafficking or direct targeting of Src to endomembranes is necessary and sufficient to initiate the CCR7-specific endomembrane signaling complex comprising Vav1.
b-Arrestin and Src Jointly Drive Signal Translocation to Initiate the Endomembrane CCR7 Signaling Complex With growing evidence that Src is essential for the initiation of the endomembrane CCR7 signaling complex, we focused on the translocation of Src from the plasma membrane to endomembranes. Src is known to localize at distinct subcellular structures and for its ability to relocalize from the periphery to vesicular structures upon activation (Sandilands et al., 2004) . In line with this, active Src, visualized by staining Src phosphorylated at Y416 and using an active Src FRET biosensor (Cadra et al., 2015) , was observed both at the plasma membrane and at endomembranes upon chemokine stimulation ( Figures S4F  and S4G ). As Src can directly interact with b-arrestin (Luttrell et al., 1999) , we addressed the potential role of b-arrestins in MEFs derived from wild-type (WT), b-arrestin2 À/À single knockout, and b-arrestin1/2 À/À double knockout mice and b-arrestin1/2 À/À double knockout cells rescued with either b-arrestin1 or b-arrestin2 were transiently transfected with Vav1-YFP1 and CCR7-YFP2. Cells were stimulated with 0.5 mg/mL CCL19 or CCL21, and endomembrane CCR7:Vav1 BiFC was determined by confocal microscopy and quantified as MFI (mean ± SEM).
(legend continued on next page)
Src trafficking and the formation of the CCR7:Vav1 signaling complex. To do so, we measured CCR7-YFP2:Vav1-YFP1 interaction in mouse embryonic fibroblasts (MEFs) derived from wild-type (WT) and b-arrestin1/b-arrestin2 double-deficient mice (Kohout et al., 2001) . As expected, chemokine-driven CCR7:Vav1 BiFC was readily observed in WT MEFs ( Figure 5A) . In contrast, neither CCL19 nor CCL21 induced the signaling complex formed between CCR7-YFP2 and Vav1-YFP1 in b-ar-restin1/2 double-deficient MEFs (Figure 5A ). Chemokine-driven CCR7:Vav1 BiFC was again seen in b-arrestin2 single-deficient and in b-arrestin1/b-arrestin2 double-deficient MEFs reconstituted with either b-arrestin1 or b-arrestin2 ( Figure 5A ).
Next, we addressed whether Src conjointly with b-arrestin traffics to endomembrane-residing CCR7. Therefore, we transfected Src-YFP1 and b-arrestin2-YFP2 into HEK293 cells expressing CCR7-hemagglutinin (HA). Src:b-arrestin BiFC was observed both at the plasma membrane and at endomembranes and was significantly enhanced upon CCR7 triggering ( Figures 5B-5F ). Moreover, CCR7-HA colocalized predominantly with the chemokine-mediated b-arrestin:Src BiFC signal at endomembranes ( Figures 5D and E) . In line with our findings above, we found no evidence for a ligand bias, as Src:b-arrestin BiFC was equally induced by CCL19 and CCL21 (Figures 5B, 5D , and 5E) and was not sensitive to dynasore treatment ( Figures  5F and S5C ). Consistent with this and a previous study (Zidar et al., 2009) , both chemokines are able to recruit b-arrestin-Rluc8 to CCR7-YFP, as determined by bioluminescence resonance energy transfer (BRET), although CCL21 with a lower efficiency ( Figure S5A ). As expected, this b-arrestin recruitment to CCR7 relied on a serine/threonine cluster to be phosphorylated by GRKs located at the receptor's C terminus ( Figure S5A ). We then monitored b-arrestin-YFP2:Src-YFP1 association and translocation by BiFC and live cell imaging. Shortly after CCL19 stimulation, b-arrestin2-YFP2 complemented with Src-YFP1 ( Figure 5C ). Over time, more BiFC-labeled vesicles appeared and BiFC-derived fluorescence intensity increased. In addition, b-arrestin:Src BiFC-labeled vesicles moved toward and accumulated within peri-nuclear regions ( Figure 5C ). 3D reconstructions in fixed cells revealed that the b-arrestin:Src BiFC signal accumulated near the TGN ( Figure S5B ). These data provide evidence that CCR7 signaling, initiated at the plasma membrane, is translocated by joint trafficking of b-arrestin and Src to endomembrane-residing CCR7. There, Src phosphorylates CCR7, required for the recruitment of Vav1, to form an endomembrane-residing CCR7 signaling complex.
Blocking Vesicular Trafficking Impedes DC Migration
To investigate whether vesicular trafficking and endomembrane CCR7 signaling contributes to cell migration, we treated mDCs matured in the presence of PGE 2 with brefeldin A, which disassembles the Golgi stacks and consequently inhibits the secretory pathway. Interestingly, mDCs migrated less efficiently toward CCL19 and CCL21 if pretreated with brefeldin A (Figure 5G) . Brefeldin A treatment did not reduce the total proportion of intracellular CCR7 in mDCs ( Figure 5H ) but enforced CCR7-YFP relocalization to the ER in HEK293 cells (Figures 5I, S6A , and S6B). Notably, brefeldin A treatment also inhibited chemokine-induced formation of CCR7:Vav1 BiFC ( Figure 5J ). Cumulatively, these data suggest that endomembrane signaling, especially from the TGN, contributes to efficient DC migration in response to CCR7 ligands.
Endomembrane CCR7:Vav1 Interaction Is Key to Recruit Rac1
So far, we found that CCR7 signaling initiated upon chemokine binding at the plasma membrane results in the formation of an endomembrane-residing CCR7:Vav1 signaling complex. We also showed that b-arrestin and Src are jointly trafficking and play a key role in establishing the endomembrane-residing CCR7:Vav1 signaling complex. As Vav1 is a guanine nucleotide exchange factor (GEF) for Rac1 (Heasman and Ridley, 2008) , and because Rac activation by receptor tyrosine kinases is described to occur at endosomes to subsequently drive actin-based protrusions at the plasma membrane, resulting in cell migration (Palamidessi et al., 2008) , we addressed whether the endomembrane-residing CCR7:Vav1 signaling complex activates Rac1. Stimulation of human lymphocytes with CCR7 ligands resulted in a transient activation of Rac1 as determined by measuring GTP-bound Rac1 (B) Quantification of the Src:b-arrestin interaction determined by BiFC and flow cytometry. HEK293 cells stably expressing CCR7-HA were transiently transfected with Src-YFP1 and b-arrestin2-YFP2 and stimulated with 0.5 mg/mL CCL19 or CCL21. Data represent mean ± SEM of eight independent experiments. (C) Time series of a representative live-cell imaging experiment in HEK293 cells transiently expressing Src-YFP1 and b-arrestin2-YFP2. Cells were stimulated with 0.5 mg/mL CCL19 immediately before recording. Confocal images were taken every 10 s over a time period of 10 min. One of three experiments is shown. (D and E) HEK293 cells stably expressing CCR7-HA were transiently transfected with Src-YFP1 and b-arrestin2-YFP2 and stimulated with 0.5 mg/mL CCL19 or CCL21. CCR7 was stained using an anti-HA antibody and Src-YFP1:b-arrestin-YFP2 BiFC monitored by confocal microscopy. Shown are representative images of one experiment out of three (E) and analysis of MFI of BiFC and quantification of BiFC-vesicles (D) (mean ± SEM). (F) HEK293 cells stably expressing CCR7-HA were transiently transfected with Src-YFP1 and b-arrestin2-YFP2, pretreated with dynasore (80 mM) for 30 min, and stimulated with 0.5 mg/mL CCL19 or CCL21. Shown is quantification of BiFC-vesicles of three independent experiments (mean ± SEM). (G) Migration of human mDCs matured in the presence of PGE 2 , pretreated or left untreated with 5 mg/mL brefeldin A for 2 h. Cells were allowed to migrate in response to 0.1 mg/mL CCL19 or CCL21 in transwell migration assays. Individual values of five different donors are shown. (H) Cell-surface and intracellular levels of CCR7 in mDCs that were pretreated with brefeldin A (5 mg/mL) or vehicle (ethanol) were determined by flow cytometry as outlined in Figures S1A and S1B. Depicted are independent experiments of four healthy donors. (I) Intracellular CCR7 localizes at the ER after brefeldin A treatment. HEK293 cells stably expressing CCR7-GFP were pretreated with brefeldin A (5 mg/mL) or control (ethanol). Colocalization of CCR7-GFP and Climp63 was analyzed by confocal microscopy and measuring Pearson's correlation coefficient (mean ± SEM). (J) CCR7:Vav1 BiFC is not formed in brefeldin-A-treated cells. HEK293 cells were transiently transfected with CCR7-YFP2 and Vav1-YFP1. Before stimulation with 0.5 mg/mL CCL19 or CCL21, cells were pretreated with brefeldin A (5 mg/mL) or vehicle (ethanol). MFI of BiFC was measured on confocal images (mean ± SEM) for three independent experiments. See also Figures S5 and S6. by flow cytometry and GLISA (Figures S7A and S7B ). In addition, active Rac1 partially associated with the CCR7:Vav1 BiFC signal in chemokine-stimulated HEK293 cells ( Figure S7C ). Next, we addressed whether CCR7 interacts with Rac1 using BiFC. As expected, Rac1-YFP2 did not complement with CCR7-YFP1 in the absence of chemokines ( Figure 6A ). However, chemokine stimulation resulted in profound recruitment of Rac1-YFP2 to CCR7-YFP1 in the presence of Vav1 ( Figure 6A ). Remarkably, chemokine-driven CCR7:Rac1 BiFC was not only confined to endomembranes but was also prominently observed at the plasma membrane and, more precisely, at membrane protrusions necessary for cell migration (Figures 6A and 6C ; Video S4). Notably, in the absence of Vav1, Rac1 was not recruited to CCR7 (Figure 6B) , corroborating the importance of the endomembrane-residing CCR7:Vav1 signaling complex for local Rac1 activation. To substantiate these findings, we expressed photoactivatable (PA)-Rac1-mCherry (Wu et al., 2009) in HEK293 cells stably transfected with the TGN marker TGN38-CFP. Photoactivation of Rac1 at the TGN area resulted in local lamellipodia formation at the plasma membrane (Figures 7A-7D ). Hence, local activation of Rac1 at endomembranes led to a reorganization of the actin cytoskeleton initiated at endomembranes and subsequently at the cell's leading edge, where lamellipodia were formed.
In summary, we identified an endomembrane-residing pool of CCR7 in human primary leukocytes. We show that the TGN and the Golgi preferentially orient toward the leading edge of mDCs migrating in 3D along chemokine gradients and demonstrate that chemokine sensing initiates conjoint trafficking of b-arrestin and Src to endomembranes, where a signaling complex is formed to spatially activate Rac1, a prerequisite for lamellipodia formation.
DISCUSSION
Here, we uncovered an endomembrane-residing CCR7 signaling complex. Intracellular localization of CCR7 (Schaeuble et al., 2012) and CCR5 (Achour et al., 2009 ) has been noted previously. However, the existence and role of the intracellular CCR5 remain controversial; one group described that CCR5 in T cells is stored in the ER and exported to the plasma membrane upon association with CD4 (Achour et al., 2009) , whereas another group denies its existence (Pilch-Cooper et al., 2011) . In the present study, we detected only a minor intracellular CCR5 pool in T cells and mDCs. We showed that newly synthesized CCR5 rapidly traffics to the plasma membrane and is not stored intracellularly. In contrast, CCR7 was profoundly expressed as intracellular pool in mDCs. We found that the intracellular pool of CCR7 localized at endomembranes, including the TGN, is fueled by steadystate trafficking as well as by de novo synthesis. We observed that the TGN and the Golgi frequently orient toward the leading edge of migrating mDCs. Interestingly, an ''internal compass'' has been proposed based on studies in the model organism Dictyostelium, where chemotactic receptors are homogeneously expressed on the entire cell surface, whereas signaling required for migration is local and polarized (Franca-Koh and Devreotes, 2004) . We extend this concept by proposing that chemokine-sensing drives an endomembrane CCR7 signaling complex that supports directional migration. Notably, disturbing the endomembrane architecture by interfering with vesicular trafficking affected CCR7-mediated mDC migration, suggesting that DCs are able to exploit such an intracellular ''compass'' activity to guide cell migration.
Chemokine-driven receptor internalization and desensitization has long been considered just to terminate signaling. Accordingly, a potential role of endomembrane-residing chemokine receptors in signal propagation is not known. The concept of endosomal signaling has been boosted by recent studies on non-chemokine receptors that challenge the old paradigm of confined GPCR signaling from the plasma membrane (Irannejad and von Zastrow, 2014) . Signaling from endomembranes might help to explain how CCR7 signaling can be maintained to guarantee sustained directed migration despite rapid receptor endocytosis. The model of such a biphasic GPCR activation is appealing as it combines initial but transient signaling from the plasma membrane with sustained signaling from endomembranes (Bahouth and Nooh, 2017; Ellisdon and Halls, 2016) . Endosomal signaling is typically mediated in a G-protein-dependent manner (Tsvetanova et al., 2015) as exemplified for b 2 AR that couples to G s for sustained cAMP production (Irannejad et al., 2013) . Similarly, binding of FTY720P to S1P1 retained signaling activity for hours, despite receptor internalization, to maintain cell motility (Mullershausen et al., 2009) . In line with these observations, persistent signaling of GPCRs is considered to depend on ligand-driven receptor internalization mediated by b-arrestins (Pavlos and Friedman, 2017) . It is supposed that endosomal receptor-b-arrestin complexes control endosomal G-protein signaling (Vilardaga et al., 2014) , which is supported by the identification of so-called supercomplexes comprising GPCR, G-protein, and b-arrestin (Thomsen et al., 2016) . However, b-arrestins play a more complex role in GPCR signaling. b-arrestin2 can mediate mitogen-activated protein kinase (MAPK) signaling at clathrincoated structures while being spatially separated from the activating b 1 AR (Eichel et al., 2016) . Moreover, b-arrestins can remain active after dissociation from the receptor to mediate receptor-independent actions before returning to an inactive state, allowing signal amplification (Lee et al., 2016; Nuber et al., 2016) . Different GPCRs were found to modulate diverse conformational changes of b-arrestin, allowing further variation of downstream signaling (Lee et al., 2016; Nuber et al., 2016) . Such versatile adaptation modes have been identified for b 2 AR; slow but sustained ERK activation solely depended on b-arrestin, whereas fast and transient ERK activation uniquely relied on G-protein coupling (Shenoy et al., 2006) . Here, we discovered that b-arrestins act as scaffold to bind Src upon CCR7 triggering. CCR7 signaling initiated at the plasma membrane is translocated by joint trafficking of b-arrestin and Src to endomembrane-residing CCR7. The formation of the endomembrane-residing CCR7 signaling complex occurs independent of G i -coupling and extends the concept of a Src-dependent ''second wave'' signaling of b 2 AR (Luttrell et al., 1999) . Although technical limitations do not permit the conclusion that the discovered endomembrane-residing signaling complex is essential for sustained CCR7 signaling and persistent leukocyte migration, our data cumulatively support such a concept. Our finding is in line with the active role of Src in controlling actin-dependent movements of endosomes toward the plasma membrane (Sandilands et al., 2004) . Furthermore, endomembrane compartments play an important role in establishing and maintaining cell polarity and hence are proposed to serve as an internal compass facilitating directional migration (Ridley et al., 2003) . Among different small GTPases, GAPs, and GEFs, Rac1 resides at endomembranes. Notably, Rac1 together with its RhoGEF, b-PIX, controls actin polymerization to give rise to carriers that drive the export of cargo from the TGN (Anitei et al., 2010) . Moreover, TGN-residing Rac1 (Baschieri et al., 2014) or endosomal Rac1 (Palamidessi et al., 2008) regulates actin nucleation in response to growth factors, thereby promoting endothelial cell migration. In line with this, active Rac1 was also observed in migrating neutrophils (Ramadass et al., 2019) . Here, we found that the RhoGEF Vav1 is recruited to endomembrane-residing CCR7. Mechanistically, we provide evidence that Src phosphorylates CCR7 to create a docking site for the SH2 domain of Vav1. This Vav1 interaction with CCR7 at endomembranes is critical for Rac1 recruitment to CCR7. Our data support the concept that endomembrane CCR7 signaling and trafficking of Rac1 is required for spatial restriction of signaling in directional cell migration (Palamidessi et al., 2008) .
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Daniel F. Legler (daniel.legler@bitg.ch) . Plasmids and cell lines generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Blood donation for research purposes was approved by the ethics committee of the University of Konstanz and individual donors gave written consent. PBMCs from healthy donors (male and female) were enriched by density gradient centrifugation on Ficoll-Paque Plus (Amersham Biosciences). Monocytes were separated from PBLs using anti-CD14-conjugated microbeads (Miltenyi). Monocytes (2x10 6 cells/ml) were then differentiated to immature DCs in serum-free AIM-V medium (GIBCO), supplemented with 50ng/ml IL-4 and 50ng/ml GM-CSF (PeproTech) as described . At day 6 immature DCs were harvested and matured for 2 days in IL-4/GM-CSF-containing medium by adding the cytokine cocktail comprising 20ng/ml TNFa, 20ng/ml IL-6 and 10ng/ml IL-1b (PeproTech) in the presence or absence of 1 mg/ml PGE 2 (Cayman). PBLs, CD19 + sorted (Miltenyi) B cells and CD3 + sorted (Miltenyi) T cells were cultured in RPMI-1640 medium supplemented with 2% human AB serum (Lonza). Activated, CCR5 expressing, T cells were obtained by culturing CD3 + sorted cells for 9 days on anti-CD3/anti-CD28 coated dishes. Human embryonic kidney 293 (HEK293) cells (female), taken from a previous hosting lab and originally obtained from ATCC (Manassas, VA, USA), have been used in our lab to first describe an intracellular CCR7 receptor pool . HEK293 cells were grown and maintained in Dulbecco's modified Eagle's medium containing 10% FCS (Lonza) and 1% Pen/Strep (Lonza) and are routinely tested for mycoplasma contamination using the MycoAlert Mycoplasma Detection Kit (Lonza). HEK293 cells were transiently transfected by TransIT-LT1 (MirusBio), according to the manufacturer's protocol. For siRNA transfection of HEK293 cells HiPerFect transfection reagent (QIAGEN) was used according to the manufacturer's protocol. HEK293 cells stably expressing CCR7-HA or CCR7-YFP were previously described (Otero et al., 2006 (Otero et al., , 2008 . For stable transfection of HEK293 cells with Vav1-YFP, TGN38-FRB-CFP, and PM2-FRB-CFP lines were cultured in presence of antibiotics after transfection and positive cells were single-cell sorted via FACS.
Mouse embryonic fibroblasts (MEFs), as well as b-arrestin2 À/À and b-arrestin1/2 À/À MEFs (Kohout et al., 2001) were kindly provided by the Lefkowitz lab and grown and maintained in Dulbecco's modified Eagle's medium containing 10% FCS (Lonza) and 1% Pen/Strep (Lonza). MEFs were transiently transfected by Lipofectamine 3000 (Life technologies), according to the manufacturer's protocol. Three-dimensional migration of primary human mDCs matured in presence of PGE 2 were performed in m-slide chemotaxis chambers (Ibidi) as described (Purvanov et al., 2018) . Golgi and nucleus in mDCs were labeled with the Golgi ID â Green assay kit (Enzo Life Sciences) as described by the manufacturer.
Quantitative real-time PCR Total RNA of MoDCs was isolated using the RNeasy Mini kit (QIAGEN) and transcribed into cDNA using random hexamer primers and the Hi Capacity cDNA Reverse Transcription kit (Applied Biosystems). Amplification of transcripts was performed using the Fast SYBR Green PCR Master Mix and CCR7 primers from QIAGEN on a 7900HT Fast Real-Time PCR System (Applied Biosystems) according to the manufacturer's instructions. Expression of CCR7 mRNA was normalized to the house-keeping genes ubc and b2-microglubulin using the 2^(-D(Ct)) method.
Preparation of cell lysates 1x10 6 MoDCs were lysed in lysis buffer (10mM Tris-HCl, 150mM NaCl, 2mM MgCl 2 , 10% glycerol, 0.4% N-dodecyl maltoside, supplemented with proteinase inhibitor mix (Roche), pH7.5) and total protein concentration was determined using the 660nm Protein Assay (Pierce). Total protein amount was adjusted and cell lysates were transferred to SDS-PAGE gels and western blot analysis was performed using indicated antibodies.
Rac1-GLISA
Chemokine-mediated Rac1 activation, monitored by measuring GTP-loaded Rac1, was assessed using the Rac1-GLISA Activation Assay Kit (Colorimetric Based) 96 assays (Cytoskeleton) according to the manufacturer's protocol. Briefly, for each condition, 2x10 7 PBLs were left untreated or stimulated with 0.5mg/ml CCL19 or CCL21 for the indicated time. Absorption derived from specific Rac1 activity was measured on a Tecan Sunrise plate reader.
Rac1-GTP measurement by flow cytometry CD3 + T cells were left untreated or stimulated with 0.5mg/ml CCL19 or CCL21 for 3min. Subsequently, cells were fixed in 4% PFA and permeabilized in 0.1% saponin. Rac1-GTP staining was performed in PBS, 0.1% saponin, 0.5% BSA. After 1h of incubation at RT, cells were washed and incubated with an AlexaFluor 488 coupled secondary antibody for 30min. Cells were then resuspended in PBS and analyzed on a LSRII flow cytometer (BD Biosciences). For each analysis, the first 10'000 cells within the gate for single cells were measured and analysis was performed using FlowJo 7.
QUANTIFICATION AND STATISTICAL ANALYSIS
For all figures, error bars show mean ± SEM. Significant differences between groups were assessed using either 1way or 2way ANOVA, with either Tukey or Bonferroni post-test, as specified in the corresponding figure legends, using GraphPad Prism 6 (GraphPad Software). Differences were considered as significant for p values of *p < 0.05; ** p < 0.01; ***p < 0.001; ****p < 0.0001.
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